1. Home
  2. CHPT vs BDSX Comparison

CHPT vs BDSX Comparison

Compare CHPT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChargePoint Holdings Inc.

CHPT

ChargePoint Holdings Inc.

HOLD

Current Price

$7.55

Market Cap

190.2M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$16.12

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHPT
BDSX
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.2M
143.2M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
CHPT
BDSX
Price
$7.55
$16.12
Analyst Decision
Hold
Strong Buy
Analyst Count
9
5
Target Price
$9.25
$32.50
AVG Volume (30 Days)
483.1K
67.6K
Earning Date
06-03-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$411,224,000.00
$88,499,000.00
Revenue This Year
$4.18
$25.26
Revenue Next Year
$16.63
$19.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.58
$0.26
52 Week High
$12.62
$20.21

Technical Indicators

Market Signals
Indicator
CHPT
BDSX
Relative Strength Index (RSI) 64.56 63.97
Support Level $7.30 $13.46
Resistance Level $12.62 $16.38
Average True Range (ATR) 0.51 1.04
MACD 0.12 0.15
Stochastic Oscillator 77.40 73.25

Price Performance

Historical Comparison
CHPT
BDSX

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: